Next Article in Journal
HIGA: A Running History Information Guided Genetic Algorithm for Protein–Ligand Docking
Previous Article in Journal
Metabolic Characterization of the Anthocyanidin Reductase Pathway Involved in the Biosynthesis of Flavan-3-ols in Elite Shuchazao Tea (Camellia sinensis) Cultivar in the Field
Previous Article in Special Issue
Two-Ply Composite Membranes with Separation Layers from Chitosan and Sulfoethylcellulose on a Microporous Support Based on Poly(diphenylsulfone-N-phenylphthalimide)
Article Menu
Issue 12 (December) cover image

Export Article

Open AccessArticle
Molecules 2017, 22(12), 2240;

Design of New-Generation Usable Forms of Topical Haemostatic Agents Containing Chitosan

R&D Project Department, Institute of Security Technologies MORATEX, Lodz 90-505, Poland
Team of Biomaterials, Institute of Biopolymers and Chemical Fibres, Lodz 90-570, Poland
Author to whom correspondence should be addressed.
Received: 2 November 2017 / Revised: 28 November 2017 / Accepted: 12 December 2017 / Published: 15 December 2017
Full-Text   |   PDF [11241 KB, uploaded 16 December 2017]   |  


Designing usable forms of topical haemostatic agents is the most important activity during the design process, resulting in strengthened functional properties of the final medical devices. This study aimed to propose indications for a research programme based on risk management supporting the development of two usable forms of a topical haemostatic agent: chitosan/alginate lyophilized foam and chitosan/alginate impregnated gauze. Both of the usable forms of the topical haemostatic agent, being the main part of the modified combat gauze, were fabricated using the chitosan/alginate complex. Risk analysis is helpful in developing an appropriate research programme, significantly reducing the risk to an acceptable level. View Full-Text
Keywords: chitosan; risk analysis; designing; haemostatic agents chitosan; risk analysis; designing; haemostatic agents

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Zielińska, D.; Struszczyk, M.H.; Madej-Kiełbik, L.; Chmal-Fudali, E.; Kucharska, M.; Wiśniewska-Wrona, M.; Brzoza-Malczewska, K. Design of New-Generation Usable Forms of Topical Haemostatic Agents Containing Chitosan. Molecules 2017, 22, 2240.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top